For that purpose, we conducted a comprehensive literature search on PubMed for studies published between 2007 and 2025, using keywords such as “bimekizumab”, “IL-17”, “IL-17A”, “IL-17F”, “psoriatic arthritis”, and “ankylosing spondylitis”. Here, IL17A is linked to psoriatic arthritis.